03 01-病毒性肝炎

200
病毒性肝炎 病毒性肝炎 中山大学附属第三医院传染病 高志良

Transcript of 03 01-病毒性肝炎

  • viral hepatitis

  • HAVHAVRNAPicornavirus198172RNAHeparnavirusHAVHAV27~32nmRNA

  • HAV HAV20

  • HAV11IgM36IgG

  • HBV HBVDNAHepadnavirusDNA

  • 1525nm22nm50230nm42nm HBV120000

  • HBVDane HBV HBV

  • DaneDane HBsAg DNADNAPHBcAg HBeAg

  • HBVHBV DNADNA 3182bpL SCPXS HBV

  • HBV

  • HBV DNA HBVRNADNA

  • HCV 1989HCV1991HCVFlavivirus

  • HCVHCVHCVvirus-like particlesVLPsHCV VLPs55nm 33nm RNA

    HCV

  • HCVCEP7NS NS2NS3NS4NS5 NS4NS5AB55NCR3 3NCR

    HCV

  • CE1E2NS2-NS5

  • 5NCRHCV3NCRHCV RNA

  • quasispeciesHCVRNA

  • Simmonds HCVHCV16 1231a1b1c2a2b2c3a3b4a5a6a1994HCV

  • HDV HDVArenaviridae Deltavirus HDV

  • HDV3537nmDNA HBsAg

  • HDVHBVDNAWHVHDV RNAHBVHDVHBV

  • HDVRNA1679bp-antigenomic strandantisense strandRNAHDVHDVRNAORF-ORF5HDAgORF

  • HDVHDV3HDVAB

  • HDV RNARNA

    RNAPRNARNARNA HDV RNA GRNAAG-RNAXGAGRNA

  • HDVHBVHBVHBVHDVHDVHBV

  • HEV1989HEV Calicivirus

  • CaliciviridaeHEVNodaviridaehepatitis E-like viruses

  • HEV HEVHEV2734nm

  • HEVRNA 7.5kb3ORFORF-1ORF-2ORF-3

    HEV

  • HGVGBV-C1995HGVGBV-C/HGVRNA100nm

  • l997NishiZdwdTT500bpN22TTV 19970KamotoTTVTTV

  • TTVDNA3050nmDNA

    TTVSF-21

  • TTV3.8kb1.2kb2.6kbORFORF1ORF2

    TTV

  • TTVTTV6G1-G6G1 G2G311

  • 2ALT1

  • 1988HAV

  • HBV

  • HBs

  • HBsAg

  • HCV

  • HCV

  • HDVHBV

  • HBVHDVHBV HBVHDVHBV

  • HEV

  • HEV 1988~1989

  • HAVNKCD8+THAV

  • HBVT/B/CD8+HBcAgMHC-CD4+BHBsAgHBcAgMHC-B-HBs

  • HCVHCV HCVCD8+HCV

  • HCVHCVHCVHCV

  • CD8+ THDV

  • HEVHEV()TCTLNK

  • HCV

  • 1 2 3 4

  • PN BN3-P-PBN-P-CBN-C-CBN14S14

  • 14GradeG14StageS

  • G12S02G3S13G4S24

  • () 1/2

  • 1.VP2. 12

  • TCTLThHBsAb Arthus

  • -GABA

  • DIC

  • DIC

  • 1457d26 12

  • 5

  • Co-infection Superinfection

  • 12

  • 0.2%~0.5%: HBVC ; , PTA
  • acute liver failure, ALF fulminant hepatitis :2

  • subacute liver failure, SALF: 15d26 : : : Hb3

  • acute-on-chronic liver failure, ACLFchronic liver failure, CLF

  • TB171mol/L17.1mol/L 30PTA40

  • / 20PTA30

  • PTA20

  • -GTGGTALPAKPTBACHOALT,ASTPTPTA60

  • Child-Pugh AChild-Pugh BC35g/LA/G1.035mol/L60%

  • HBVHBsAg

  • ALTASTALTALP-GTCHE

  • 171mol/L/A/G

  • PTPTA40%PTHAPC--CLN

  • -HAV IgMHAVHAV-HAV IgG

  • HBsAg-HBs HBsAgHBVHBsAgHBVS-HBsHBV-HBsHBVHBVHBsAg-HBsHBsAg-HBs

  • HBeAg-HBe HBeAgHBV-HBeHBVHBV DNADNACHBeAg

  • HBcAg-HBc HBcAgDaneHBV-HBc IgMHBV-HBc IgG

  • HBV DNA

  • HBsAg HBsAg400 HBcAg HBcAg 400 HBVHBsAgHBcAgHBV DNA

  • -HCVHCV-HCV IgM-HCV IgGHCV1~2HCV RNA

  • HDAg-HDVHDAg-HDV IgM-HDV IgGHBVHDV-HBc IgM-HDVHBVHDV-HBc IgM-HDVHDV RNAHDV

  • -HEV IgM-HEV IgGHEVRT-PCRHEV RNA

  • PCR

  • BTHBVHCV

  • HBsAg

  • ALT6

  • HBsAgB3

  • BB/

  • () : 21526

  • 3

  • B

  • -HAV IgMHAV-HAV IgM

  • HBsAg-HBs-HBc IgM-HBc IgG a.HBeAgHBsAgHBV DNAHBeAg-HBeALT b.HBeAgHBsAgHBV DNAHBeAg-HBeALT

  • 3.a.Child-Pugh AALTASTb.Child-Pugh BC35 mol/LALTAST(PTA)
  • 4.HBV a.HBVHBsAgHBV DNAHBeAg-HBe13ALTASTb.HBsAgHBsAgHBeAg-HBeHBV DNA(PCR)13ALT:Knodell ( HAI)
  • HCV RNA-HCV-HCV/HCV RNA

  • HDV HBVHBV-HDV IgM-HDV IgG/HDV AgHDV RNAHDVHBVHBsAgHDV RNA/HDV Ag-HDV IgM-HDV IgGHDV RNA/HDV Ag-HDV IgGHDV RNAHDV RNA/HDV Ag

  • -HEV-HEV1:20RT-PCR/HEV RNA-HEV IgM

  • 310%~40%HBV70%1%5%10%40%

  • 50%~70%80%

  • 8001000mg/d

  • HBVALTHCV RNA+/-HCV+ALT

  • 2

  • 35MU5MU311PEG1118

  • ALTHBV DNAHBeAgHBsAgALTHBV DNAHBeAgHBsAg612612ALTHBV DNA

  • ALTHCV RNAALTHCV RNAHCV RNA ALTALTHCV RNA612612ALTHCV RNA

  • 24h

  • ()(): :

  • ()HBV

  • A(lamivudine)100mg (adefovir dipivoxil)10mg (entecavir)0.5 mgYMDD1mg 10 (telbivudine) 600 mgFDAB

  • : HBeAg:HBeAg 1; HBeAg:2 : ()

  • 5%10%BCK

  • -G-I1mg10U10500ml1/d14HGF120200mg/d E1 (PGE1)1020g/d

  • :( )

  • :

  • HBV(HBV DNA104 /ml)

  • artificial liver support system ALSS

  • PTA20%40%50109/L

  • DIC

  • 3HBsAgHCV RNA/ / HBIG -HBV IgG

  • //

  • AFPPTA HBIG

  • :

  • 18 64, 39, 5

  • HBsAg (+)T 37P70/BP100/70mmHg1.5cm: (+) (-)84mol/L 60mol/LALT200u/L

  • ?? ()

  • ..2005Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B.Zhonghua Ganzangbing Zazhi,2005,13:881-891...200513881-891PolsonJ,LeeWM.AmericanAssociationfortheStudyofLiverDisease.(AASLD)PositionPaper:TheManagementofAcuteLiverFailure.Hepatology.2005,41:1179-97